The Portfolio Diet and HbA1c in Adults Living with Type 2 Diabetes Mellitus: A Patient-Level Pooled Analysis of Two Randomized Dietary Trials

Author:

Kavanagh Meaghan E.12,Back Songhee12ORCID,Chen Victoria12,Glenn Andrea J.123,Viscardi Gabrielle12,Houshialsadat Zeinab12,Sievenpiper John L.12456,Kendall Cyril W. C.127,Jenkins David J. A.12456ORCID,Chiavaroli Laura124

Affiliation:

1. Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada

2. Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Center, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada

3. Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA 02115, USA

4. Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada

5. Division of Endocrinology and Metabolism, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada

6. Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada

7. College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada

Abstract

(1) Background: The Portfolio Diet, a dietary pattern of cholesterol-lowering foods, is also rich in low glycemic index (GI) foods. While strong evidence supports clinically meaningful reductions in cholesterol, evidence on the relationship between the Portfolio Diet and diabetes management is lacking. (2) Objective: To evaluate the relationship between the Portfolio Diet and glycated hemoglobin (HbA1c) as a determinant of glycemic control among adults living with type 2 diabetes mellitus (T2DM). (3) Methods: Patient-level data was pooled from two randomized dietary trials of low glycemic index interventions compared to high cereal fibre control diets in adults living with T2DM where HbA1c was collected (clinicaltrials.gov identifiers: NCT00438698, NCT00438698). Dietary exposure was assessed using weighed 7-day diet records. Adherence to the Portfolio Diet and its pillars (nuts and seeds, plant protein, viscous fibre, plant sterols, monounsaturated fatty acid [MUFA] oils) was determined using the validated clinical Portfolio Diet Score (c-PDS). Multiple linear regression was used to assess the association between change in the c-PDS and change in HbA1c over 6-months with covariate adjustments. (4) Results: A total of 267 participants, predominantly White (67%) and male (63%), were included, with a mean ± standard error age of 62 ± 0.5 years, baseline BMI of 30.2 ± 0.3 kg/m2, HbA1c of 7.08 ± 0.03%, and a c-PDS of 4.1 ± 0.3 points out of 25. Change in the c-PDS was significantly associated with a change in HbA1c (β: −0.04% per point, 95% CI: −0.07, −0.02, p = 0.001). A 7.5-point (30%) increase in the c-PDS was associated with a 0.3% reduction in HbA1c. Of the individual pillars, a 1-point change in nut and seeds intake (β: −0.07%, 95% CI: −0.12, −0.02, p = 0.009) or in plant protein intake (β: −0.11%, 95% CI: −0.18, −0.03, p = 0.009) was associated with a change in HbA1c. Further analysis of plant protein intake revealed that an increase in dietary pulse intake, a particularly low-GI food, was significantly associated with a reduction in HbA1c (β: −0.24% per 1-cup points cooked pulses (226 g) or 2 c-PDS points, 95% CI: −0.45, −0.03, p = 0.028). (5) Conclusions: Among adults living with T2DM, the Portfolio Diet was associated with lower HbA1c over a 6-month period, predominantly driven by two pillars: nuts and seeds and plant protein, particularly dietary pulses. These data have implications for including the Portfolio Diet in dietary recommendations for glycemic control in T2DM. A trial demonstrating the direct causal effect of the Portfolio Diet in a diverse group is warranted.

Funder

Canadian Institutes of Health Research (CIHR) Canadian Graduate Scholarship Doctoral Award

CIHR Canada Graduate Scholarship—Masters (CGS-M) Research Award

University of Toronto Department of Nutritional Sciences Fellowship

CIHR Postdoctoral Fellowship Award and Toronto 3D Postdoctoral Fellowship Top-up Award

CIHR Canada Graduate Scholarship—Masters (CGS-M) Research Award and a University of Toronto Department of Nutritional Sciences Fellowship

University of Toronto Department of Nutritional Sciences Fellowship and a Toronto 3D Ph.D. Scholarship award

the Government of Canada through the Canada Research Chair Endowment

PSI Graham Farquharson Knowledge Translation Fellowship

Canadian Diabetes Association Clinician Scientist Award

Canadian Institute of Health Research INMD and CNS New Investigator Partnership Prize

Banting & Best Diabetes Centre Sun Life Financial New Investigator Award

Toronto 3D New Investigator Award

Publisher

MDPI AG

Reference61 articles.

1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021;Ong;Lancet,2023

2. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021;Brauer;Lancet,2024

3. The cost of diabetes in Canada over 10 years: Applying attributable health care costs to a diabetes incidence prediction model;Bilandzic;Health Promot. Chronic Dis. Prev. Can.,2017

4. Diabetes Canada (2024, March 02). Diabetes 360: A Framework for a Diabetes Strategy for Canada, Recommendations for Governments July 2018. Available online: https://www.diabetes.ca/DiabetesCanadaWebsite/media/Advocacy-and-Policy/Diabetes-360-Recommendations.pdf.

5. Contemporary medical, device, and surgical therapies for obesity in adults;Perdomo;Lancet,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3